LATEST NEWS

HTC Alum Xenex Debuts Hospital-Cleaning “Pod” After Adding $38M

June 14, 2017

Houston Technology Center alum, Xenex Disinfection Services, a healthcare company that raised $38 million in February, is now selling a


Houston Technology Center Grad Pulmotect Convenes Inaugural Scientific Advisory Board

June 8, 2017

Members of the board, from both the United States and Europe, convened with Pulmotect’s management team to discuss the company’s


HTC North Has New Green Campus

June 7, 2017

The Houston Technology Center’s North Campus, home of Innovators in the Woods, is joining HARC (Houston Advanced Research Center) at


HTC Alumn OrthoAccel Receives FDA Clearance for New Tech

June 6, 2017

Houston Technology Center graduate OrthoAccel® Technologies, Inc. announced that it has received FDA clearance for its newest accelerated treatment device,


HTC Client Takes Second Place in HCC-Newspring Business Plan Competition

May 18, 2017

Houston Community College (HCC) and the Spring Branch nonprofit organization Newspring held their annual Business Plan Competition Awards Ceremony on


Making Houston a Hub for Innovation, GHP Launches Innovation Strategy Office

May 16, 2017

Houston Technology Center CEO Lori Vetters joined Gina Luna, chair of the Greater Houston Partnership’s Houston Innovation Roundtable and Ed


Business Groups Launch Innovation Strategy Office To Boost Houston Tech

May 15, 2017

Houston’s business leaders have nailed down their plan amp up the city’s entrepreneurial ecosystem, with the launch of a “strategy


HTC Company Shower Stream Selected to Compete in Texas A&M New Ventures Competition

April 28, 2017

HTC client company Abstract Engineering has been selected to compete in this year’s Texas A&M New Ventures Competition (TNVC).  The


HTC Grad Adhesys Acquired by German Pharmaceutical

April 10, 2017

The Grünenthal Group today announced the acquisition of the company Adhesys Medical to expand its pipeline of medical devices for


Néstor Molfino

Pulmotect Announces Appointment of Néstor Molfino, MD as President and Chief Executive Officer

March 22, 2017

Pulmotect, Inc., a clinical-stage biotechnology company developing an inhaled pathogen-agnostic, host-directed immunomodulator (PUL-042), announces that Respiratory Medicine specialist Néstor A.